Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear | BMJ Evidence-Based Medicine

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Commentary

General medicine

Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear

Online download statistics by month:

Online download statistics by month: December 2018 to August 2022

	Abstract	Full	Pdf
Dec 2018	318	21	13
Jan 2019	107	9	4
Feb 2019	119	5	3
Mar 2019	94	3	2
Apr 2019	57	1	1
May 2019	463	19	14
Jun 2019	828	16	7
Jul 2019	757	18	9
Aug 2019	73	8	7
Sep 2019	45	2	1
Oct 2019	43	0	2
Nov 2019	30	3	3
Dec 2019	69	4	2
Jan 2020	53	2	3
Feb 2020	65	2	2
Mar 2020	35	0	0
Apr 2020	20	4	2
May 2020	58	1	0
Jun 2020	38	1	1
Jul 2020	27	3	3
Aug 2020	31	1	1
Sep 2020	35	1	0
Oct 2020	17	2	0
Nov 2020	25	2	0
Dec 2020	20	0	0
Jan 2021	25	0	0
Feb 2021	52	2	2
Mar 2021	28	1	1
Apr 2021	18	0	0
May 2021	65	0	0
Jun 2021	1	0	1
Aug 2021	3	0	0
Sep 2021	4	2	1
Oct 2021	30	1	3
Nov 2021	72	2	1
Dec 2021	32	1	0
Jan 2022	64	2	0
Feb 2022	48	0	0
Mar 2022	67	6	3
Apr 2022	45	2	3
May 2022	69	1	0
Jun 2022	56	6	0
Jul 2022	33	2	0
Aug 2022	74	0	0
Total	4213	156	95